Registration Options

Activity Dates: 10/13/2023 - 10/12/2025

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

BCPPs desiring an evidence-based focus on an emerging area of practice and contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who learn best from didactic presentations, are auditory and visual learners, and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.

 

Session Summary

Treatment guidelines for all major psychiatric illnesses recommend routine monitoring for patients receiving medications to treat those illnesses. Guidelines recommend therapeutic drug monitoring when appropriate. Adverse effect monitoring is also recommended, with a focus on movement disorders and metabolic adverse effects with antipsychotics. Despite these published recommendations, not all patients receiving psychotropic medication have this monitoring performed as recommended due to time constraints and lack of provider knowledge. As more patients with mental illness are treated within primary care settings, it is important that primary care and mental health providers work together to appropriately monitor psychotropic medications and their adverse effects. This presentation will explore how psychiatric pharmacists are in a key position to perform this monitoring, educate their colleagues, and help improve overall health outcomes for patients.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Bridget Bradley, PharmD, BCPP

View biographical information

Learning Objectives

  1. Develop a monitoring plan for a patient receiving a psychotropic medication. 
  2. Recommend adjustments to psychotropic monitoring plans in special patient populations.
  3. Implement strategies to increase appropriate monitoring of psychiatric medications in primary care settings.

Continuing Education Credit and Disclosures

Activity Dates: 10/13/2023 - 10/12/2025
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-23-014-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.